European Meeting on HIV & Hepatitis 2022
Supported by Gilead who provided funding. Gilead has had no input into the content of the materials used at this meeting/conference.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals, researchers, and community representatives involved in the development of treatment strategies and research of antiviral drug resistance in HIV, hepatitis, and emerging viruses. This collaboration plays a vital role in both the organizational as well as the scientific success of the program. To show your commitment to the cause and get in touch with us for a tailored support package, please contact Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 2307 142.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgment on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level